Study Watch vs Eko Low Ejection Fraction Tool (ELEFT)
AI Verdict
Choose Study Watch if…
Choose the Verily Study Watch if your clinical research requires continuous, long-term physiological monitoring with a diverse set of sensor data, including ECG, heart rate, and movement. This device is ideal for studies needing detailed, multi-modal data collection for in-depth analysis and the identification of subtle physiological changes over extended periods.
View Study Watch →Choose Eko Low Ejection Fraction Tool (ELEFT) if…
Choose the Eko Low Ejection Fraction Tool (ELEFT) if you need a rapid, AI-powered screening solution to aid in the early detection of low ejection fraction during routine physical examinations. This tool is best suited for clinicians seeking to quickly identify patients at risk for heart failure within a standard clinical encounter, leveraging integrated digital stethoscope technology.
View Eko Low Ejection Fraction Tool (ELEFT) →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Study Watch | Eko Low Ejection Fraction Tool (ELEFT) |
|---|---|---|
| Deployment | The Study Watch is a wrist-worn, multi-sensor wearable device used for data collection in clinical trials. Data from the watch is encrypted and sent securely to the Verily Cloud using a USB syncing and charging cradle and a wireless connectivity bridge (Verily Study Hub). | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Eko Low Ejection Fraction Tool (ELEFT)ELEFT integrates directly into a familiar clinical workflow using a stethoscope, providing rapid, actionable results within 15 seconds during a routine physical exam. This offers superior usability for clinicians compared to the Study Watch, which is a wearable primarily for continuous data collection in clinical research settings.
Clinical Value
Eko Low Ejection Fraction Tool (ELEFT)ELEFT provides immediate, actionable clinical value by aiding in the early detection of a critical condition (low ejection fraction) during routine patient encounters, potentially leading to earlier intervention and improved patient outcomes. While Study Watch offers valuable continuous data for research, its direct clinical impact on immediate patient care is less pronounced than ELEFT's diagnostic support.
Pricing & Value
TieBoth tools lack public pricing transparency, making a direct comparison of their cost-effectiveness impossible. Both are positioned as enterprise or partnership solutions, suggesting customized pricing models rather than standardized rates. Without specific financial details, it is not possible to definitively determine which offers better value.
Enterprise Readiness
Eko Low Ejection Fraction Tool (ELEFT)Both tools demonstrate strong enterprise readiness with FDA clearance, cloud deployment, and HIPAA compliance with BAAs. However, Eko Health explicitly states MDSAP and ISO 13485:2016 certifications, which further underscore its commitment to quality management systems and regulatory compliance for enterprise deployments.
Innovation
Study WatchStudy Watch demonstrates broader innovation through its multi-sensor, continuous physiological monitoring capabilities, collecting a rich and diverse dataset for clinical research and advanced machine learning analysis. This foundational approach to comprehensive data acquisition pushes the boundaries of understanding health and disease more broadly than ELEFT's targeted diagnostic algorithm.
Support & Docs
Eko Low Ejection Fraction Tool (ELEFT)Eko Health provides a more comprehensive and publicly accessible support ecosystem for ELEFT, including a detailed Help Center, various direct contact options (phone, email, support tickets), and readily available user manuals. Verily's support for Study Watch appears more tailored to its research and partnership model, with less explicit public-facing support channels for individual users.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Study Watch | Eko Low Ejection Fraction Tool (ELEFT) |
|---|---|---|
| Name | Study Watch | Eko Low Ejection Fraction Tool (ELEFT) |
| Company | Verily Life Sciences | Eko Health |
| Primary Purpose | Non-invasive, continuous physiological monitoring in clinical research, collecting data like ECG, heart rate, and movement for analysis. | FDA-cleared AI algorithm to aid clinicians in the early detection of low ejection fraction during routine physical exams. |
| Data Collected/Analyzed | ECG, heart rate, electrodermal activity, inertial movements | ECG and heart sound recordings |
| Device Type/Integration | Prescription-only, sensor-based wearable device | AI algorithm that integrates with Eko digital stethoscopes |
| Key Feature Highlight | Continuous physiological monitoring, long battery life (up to one week), on-demand single-channel ECG, irregular pulse monitor. | AI-powered low ejection fraction detection, provides results in approximately 15 seconds, aids in early identification of heart failure risk. |
Videos
Demos, reviews, and walkthroughs featuring Study Watch and Eko Low Ejection Fraction Tool (ELEFT).
Frequently Asked Questions
More Comparisons
More matchups featuring Study Watch or Eko Low Ejection Fraction Tool (ELEFT)
Backers
Who funded each tool's parent company.